American Century Companies Inc. Raises Stock Position in Nutex Health Inc. $NUTX

Key Points

• American Century Companies Inc. has increased its holdings in Nutex Health Inc. by 73.0% in the first quarter, owning approximately 1.35% of the company, worth about $3,497,000.
• Analysts are optimistic about Nutex Health, with Maxim Group setting a price target at $205.00 and Benchmark raising its target from $150.00 to $300.00, both maintaining a "buy" rating.
• Nutex Health's current share price is $83.79, with a twelve-month price range between $17.51 and $184.27, indicating significant volatility in its market performance.

American Century Companies Inc. increased its position in shares of Nutex Health Inc. (NASDAQ:NUTX - Free Report) by 73.0% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 74,359 shares of the company's stock after acquiring an additional 31,366 shares during the quarter. American Century Companies Inc. owned approximately 1.35% of Nutex Health worth $3,497,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of NUTX. Bank of America Corp DE boosted its position in Nutex Health by 6,590.3% during the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock worth $66,000 after acquiring an additional 2,043 shares during the last quarter. Northern Trust Corp acquired a new stake in Nutex Health during the fourth quarter worth approximately $200,000. Millennium Management LLC acquired a new stake in Nutex Health during the fourth quarter worth approximately $213,000. OMERS ADMINISTRATION Corp acquired a new stake in Nutex Health during the fourth quarter worth approximately $231,000. Finally, Squarepoint Ops LLC acquired a new stake in Nutex Health during the fourth quarter worth approximately $285,000. Institutional investors and hedge funds own 5.32% of the company's stock.

Nutex Health Trading Down 2.9%

Shares of NUTX traded down $2.50 during mid-day trading on Friday, reaching $83.38. The company had a trading volume of 112,095 shares, compared to its average volume of 215,747. The stock has a market cap of $463.59 million, a price-to-earnings ratio of 7.01 and a beta of -0.17. The firm has a fifty day simple moving average of $99.74 and a 200-day simple moving average of $103.61. Nutex Health Inc. has a fifty-two week low of $17.51 and a fifty-two week high of $184.27. The company has a current ratio of 2.27, a quick ratio of 2.26 and a debt-to-equity ratio of 1.02.

Wall Street Analyst Weigh In

NUTX has been the topic of a number of research analyst reports. Maxim Group set a $205.00 price target on shares of Nutex Health and gave the company a "buy" rating in a report on Tuesday, August 26th. Benchmark lifted their price target on shares of Nutex Health from $150.00 to $300.00 and gave the company a "buy" rating in a report on Thursday, May 15th. Finally, Wall Street Zen lowered shares of Nutex Health from a "buy" rating to a "hold" rating in a report on Friday. Two equities research analysts have rated the stock with a Buy rating, According to MarketBeat.com, Nutex Health has an average rating of "Buy" and a consensus target price of $252.50.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.